
Advinus Therapeutics Ltd.
Interested in working with
Advinus Therapeutics Ltd.?
Overview
Advinus Therapeutics (A TATA Enterprise) is an R&D driven company that is focused on the new drug discovery and development of pharmaceutical and agrochemical products. Advinus operations are organized into two separate businesses centered around Discovery and Development respectively.
The Discovery arm of Advinus integrates under one umbrella the expertise, experience, capabilities and infrastructure needed for Drug Discovery from hit to clinical development candidate. Our presence in India helps us enhance the productivity and efficiency of our agrochemical and pharmaceutical R&D programs to unprecedented levels of cost-effectiveness and quality by bringing together demonstrated world class expertise with the talent and economies of India.
Advinus' Development business provides services to pharmaceutical, biotech and agro companies for global registration of pharma, biotech, medical devices, nutraceuticals and agrochemicals. We offer, Medicinal Chemistry, scale up to multi kilo quantities under cGMP. Our in vitro ADMET and DMPK services improve the prediction of clinically relevant adverse toxicological events for new pharmaceutical candidates and select compounds with favorable ADMET and DMPK properties to enhance the success rate of our pharma-biotech clients. The drug development and agro-chemical development services operate out of two separate locations with their own dedicated analytical infrastructure. By focusing on R&D services, Advinus is able to ensure that there is no dilution of the scientific and managerial focus because of downstream functions including manufacture, marketing and commercialization of API and finished formulations.
Standards & Methodologies
1. Medicinal Chemistry Synthesis
5. Toxicology Services
Qualifications, Certifications, Accreditations & Licenses
- GLP since 1992
- Largest AAALAC certified animal vivarium in India, one of Asia's largest regulatory toxicology facilities
- Submitted 35 complete IND packages (late lead optimization through IND) (11 with USFDA, 6 with TPP Health Canada, 6 with EMA, 2 with MHRA, 1 each with AEMPS Spain, HSA Singapore, Medsafe New Zealand, TGA Australia and NGCMA India), all of them getting FIH approvals without clinical hold
- 7000 standalone Toxicology studies submitted to regulatory agencies worldwide
- 56 Carcinogenicity studies including in RasH2 & p53 Transgenic mouse models
- Robust historical control data from sub-chronic & chronic studies in rodents (including SD rats) & non-rodents available on Body weight & feed intake, Hematology and Clinical Chemistry, Histopathology, Tumor incidence, Teratology, Mutagenicity, etc.
- 68 study directors including 6 DABTs, and over 110 scientists of whom 65% have either a Ph.D., M.S. (biology) or D.V.M degree including 25 trained histologists
- Histopathology: Team of 5 Veterinary pathologists headed by a globally preeminent pathologist with >35 years of experience who has authored over 300 safety evaluation study reports including 28 carcinogenicity studies
Lab Gallery

.jpg)


Industries Served
- Agriculture
- Biotechnology
- Chemicals
- Dietary Supplements and Nutraceuticals
- Life Sciences
- Medicinals and Botanicals
- Natural Products
- Pesticides, Herbicides and Insecticides
- Pharmaceutical
Testing Types
- Analytical
- Analytical Chemistry
- Biochemistry
- Biomedical
- Biophysical
- Clinical Trials
- Medicinal Chemistry
- Molecular Biology
- Nanotechnology
- Organic Chemistry
- Pathology
- Pharmacology
- Preclinical
- Radioactivity, Radiochemistry and Radiochemical
- Safety
- Toxicology
Publications
Advinus Therapeutics Ltd. has not posted any publications.
DISCLAIMER: This Laboratory Profile was provided by the company above.